JGC
J. Goldman & Co Portfolio holdings
AUM
$3.18B
This Quarter Return
+20.5%
1 Year Return
+9.17%
3 Year Return
+56.93%
5 Year Return
+78.85%
10 Year Return
+152.96%
AUM
$1.06B
AUM Growth
+$1.06B
(+88%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
38.18%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
321
New
105
Increased
42
Reduced
36
Closed
92
Top Buys
| 1 |
Mondelez International
MDLZ
|
$40.7M |
| 2 |
PG&E
PCG
|
$32.5M |
| 3 |
GSAH.U
GS Acquisition Holdings Corp II Units, each consisting of one share of Class A Common Stock and one-
GSAH.U
|
$28.4M |
| 4 |
Hanesbrands
HBI
|
$27.9M |
| 5 |
Netflix
NFLX
|
$27.9M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$26.9M |
| 2 |
Target
TGT
|
$18.9M |
| 3 |
CCXX.U
Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt
CCXX.U
|
$17.1M |
| 4 |
Utz Brands
UTZ
|
$15M |
| 5 |
PayPal
PYPL
|
$13.3M |
Sector Composition
| 1 | Consumer Discretionary | 23.33% |
| 2 | Communication Services | 11.51% |
| 3 | Industrials | 11.25% |
| 4 | Healthcare | 9.74% |
| 5 | Technology | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
The Mosaic Company
MOS
$10.6B
| $1.92M | 0.12% |
+153,324
| New | +$1.92M |
|
127
Rigel Pharmaceuticals
RIGL
$690M
| $1.88M | 0.12% |
1,027,046
+734,047
| +251% | +$1.34M |
|
128
Krystal Biotech
KRYS
$4.31B
| $1.87M | 0.12% |
+45,202
| New | +$1.87M |
|
|
OTIC
129
DELISTED
Otonomy, Inc.
OTIC
| $1.84M | 0.11% |
509,164
-258,648
| -34% | -$936K |
|
130
Comstock Resources
CRK
$4.8B
| $1.84M | 0.11% |
+419,443
| New | +$1.84M |
|
131
JD.com
JD
$44.8B
| $1.81M | 0.11% |
+30,000
| New | +$1.81M |
|
132
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.72M | 0.11% |
+359,944
| New | +$1.72M |
|
133
Stitch Fix
SFIX
$679M
| $1.71M | 0.11% |
68,601
-344,333
| -83% | -$8.59M |
|
134
Workhorse Group
WKHS
$19.8M
| $1.59M | 0.1% |
+91,591
| New | +$1.59M |
|
135
Deere & Co
DE
$129B
| $1.57M | 0.1% |
+10,000
| New | +$1.57M |
|
136
Penumbra
PEN
$10.5B
| $1.5M | 0.09% |
+8,412
| New | +$1.5M |
|
|
AMRN
137
Amarin Corp
AMRN
$314M
| $1.47M | 0.09% |
+212,645
| New | +$1.47M |
|
138
Polaris
PII
$3.19B
| $1.18M | 0.07% |
12,772
+8,610
| +207% | +$797K |
|
|
CCX.U
139
DELISTED
Churchill Capital Corp II
CCX.U
| $1.16M | 0.07% |
95,000
| – | – |
|
140
iShares US Medical Devices ETF
IHI
$4.3B
| $1.07M | 0.07% |
4,056
+2,093
| +107% | +$554K |
|
|
HZNP
141
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.02M | 0.06% |
18,307
-22,557
| -55% | -$1.25M |
|
|
ETRN
142
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $953K | 0.06% |
+114,696
| New | +$953K |
|
|
YVR
143
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
| $913K | 0.06% |
+666,668
| New | +$913K |
|
|
PRVB
144
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $911K | 0.06% |
64,594
+44,595
| +223% | +$629K |
|
145
Soleno Therapeutics
SLNO
$3.57B
| $882K | 0.05% |
397,374
+256,234
| +182% | +$569K |
|
146
IDT Corp
IDT
$1.62B
| $881K | 0.05% |
134,963
-46,979
| -26% | -$307K |
|
147
Protagonist Therapeutics
PTGX
$3.66B
| $872K | 0.05% |
+49,359
| New | +$872K |
|
|
PDCE
148
DELISTED
PDC Energy, Inc.
PDCE
| $866K | 0.05% |
69,652
-20,000
| -22% | -$249K |
|
149
Kura Oncology
KURA
$690M
| $853K | 0.05% |
+52,335
| New | +$853K |
|
150
TFS Financial
TFSL
$3.85B
| $805K | 0.05% |
+56,258
| New | +$805K |
|